Literature DB >> 29971936

Longitudinal Changes in Symptom Cluster Membership in Inflammatory Bowel Disease.

Samantha Conley1, Sangchoon Jeon2, Deborah D Proctor3, Robert S Sandler4, Nancy S Redeker5.   

Abstract

PURPOSE: To describe changes in symptom cluster membership over 1 year and to examine which demographic and clinical factors predict changes in symptom cluster membership among adults with inflammatory bowel disease.
DESIGN: A retrospective longitudinal study of the Crohn's & Colitis Foundation of America Partners Cohort from 2012 to 2015.
METHODS: We measured symptoms of pain interference, fatigue, sleep disturbance, depression, and anxiety. We used latent transition analysis to describe changes in symptom cluster membership (baseline, 6 months, and 12 months) and multinomial regressions to examine factors associated with symptom cluster membership transition.
FINDINGS: Four groups were identified (N = 5,296): high symptom burden (32.3%-35.3%), low symptom burden (24.2%-27.1%), physical symptoms (19.0%-20.9%; pain, fatigue, sleep disturbance), and psychological symptoms (20.0%-21.5%; depression, anxiety). The probability of staying in the same group was .814 to .905. Moving from active disease into remission was associated with moving from the high burden to low burden and psychological symptom groups.
CONCLUSIONS: Symptom cluster membership was quite stable over 1 year. Research is needed to understand the underlying etiology of symptom clusters better and to develop interventions to reduce symptom burden in this vulnerable population. CLINICAL RELEVANCE: Careful consideration of symptom management options should be done with patients to select options that are effective and potentially target multiple symptoms.
© 2018 Sigma Theta Tau International.

Entities:  

Keywords:  zzm321990PROMISzzm321990; Inflammatory bowel disease; latent transition analysis; symptom burden; symptom clusters; symptoms

Mesh:

Year:  2018        PMID: 29971936      PMCID: PMC6120775          DOI: 10.1111/jnu.12409

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  44 in total

Review 1.  Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.

Authors:  K Kroenke; R Swindle
Journal:  Psychother Psychosom       Date:  2000 Jul-Aug       Impact factor: 17.659

Review 2.  Symptom burden in inflammatory bowel disease: rethinking conceptual and theoretical underpinnings.

Authors:  Dawn Farrell; Eileen Savage
Journal:  Int J Nurs Pract       Date:  2010-10       Impact factor: 2.066

3.  Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity.

Authors:  Kelvin T Thia; Edward V Loftus; Darrell S Pardi; Sunanda V Kane; William A Faubion; William J Tremaine; Kenneth W Schroeder; Scott W Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2010-09-27       Impact factor: 5.325

4.  Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study.

Authors:  Daniel R van Langenberg; Peter R Gibson
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 5.  Gut/brain axis and the microbiota.

Authors:  Emeran A Mayer; Kirsten Tillisch; Arpana Gupta
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

6.  Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

Authors:  David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon
Journal:  Qual Life Res       Date:  2014-06-18       Impact factor: 4.147

7.  Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis.

Authors:  Yueming Tang; Fabian Preuss; Fred W Turek; Shriram Jakate; Ali Keshavarzian
Journal:  Sleep Med       Date:  2009-04-28       Impact factor: 3.492

8.  The effect of opioids on sleep architecture.

Authors:  Joel E Dimsdale; Daniel Norman; Douglas DeJardin; Mark S Wallace
Journal:  J Clin Sleep Med       Date:  2007-02-15       Impact factor: 4.062

Review 9.  The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality.

Authors:  Augusto J Montiel-Castro; Rina M González-Cervantes; Gabriela Bravo-Ruiseco; Gustavo Pacheco-López
Journal:  Front Integr Neurosci       Date:  2013-10-07

10.  Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis.

Authors:  S Landau; V Harris; D J Burn; J V Hindle; C S Hurt; M Samuel; K C Wilson; R G Brown
Journal:  Psychol Med       Date:  2015-10-23       Impact factor: 7.723

View more
  5 in total

1.  Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease.

Authors:  Kendra J Kamp; Kindra Clark-Snustad; Mitra Barahimi; Scott Lee
Journal:  Gastroenterol Nurs       Date:  2022 Jan-Feb 01       Impact factor: 0.978

2.  Symptom Profiles, Health-Related Quality of Life, and Clinical Blood Markers among Korean Community-Dwelling Older Adults Living with Chronic Conditions.

Authors:  Jongmin Park; Nada Lukkahatai; Nancy Perrin; Yoonju Kim; Leorey N Saligan; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2021-02-11       Impact factor: 3.390

3.  'It's about willpower in the end. You've got to keep going': a qualitative study exploring the experience of pain in inflammatory bowel disease.

Authors:  Louise Sweeney; Rona Moss-Morris; Wladyslawa Czuber-Dochan; Laure Belotti; Zoe Kabeli; Christine Norton
Journal:  Br J Pain       Date:  2019-04-11

4.  Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.

Authors:  Nienke Z Borren; Millie D Long; Robert S Sandler; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2021-10-20       Impact factor: 5.325

5.  Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission.

Authors:  Rosellina Margherita Mancina; Raffaele Pagnotta; Caterina Pagliuso; Vincenzo Albi; Daniela Bruno; Pietro Garieri; Patrizia Doldo; Rocco Spagnuolo
Journal:  Medicina (Kaunas)       Date:  2020-01-20       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.